VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.

Metastasis is accountable for 90% of cancer deaths. During metastasis, tumor cells break away from the primary tumor, enter the blood and the lymph vessels, and use them as highways to travel to distant sites in the body to form secondary tumors. Cancer cell migration through the endothelium and int...

Full description

Bibliographic Details
Main Authors: Susan M Hamilla, Kimberly M Stroka, Helim Aranda-Espinoza
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4183660?pdf=render
id doaj-48e085f5f7ce4501ae9ef2e61777ae20
record_format Article
spelling doaj-48e085f5f7ce4501ae9ef2e61777ae202020-11-24T20:50:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e10974810.1371/journal.pone.0109748VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.Susan M HamillaKimberly M StrokaHelim Aranda-EspinozaMetastasis is accountable for 90% of cancer deaths. During metastasis, tumor cells break away from the primary tumor, enter the blood and the lymph vessels, and use them as highways to travel to distant sites in the body to form secondary tumors. Cancer cell migration through the endothelium and into the basement membrane represents a critical step in the metastatic cascade, yet it is not well understood. This process is well characterized for immune cells that routinely transmigrate through the endothelium to sites of infection, inflammation, or injury. Previous studies with leukocytes have demonstrated that this step depends heavily on the activation status of the endothelium and subendothelial substrate stiffness. Here, we used a previously established in vitro model of the endothelium and live cell imaging, in order to observe cancer cell transmigration and compare this process to leukocytes. Interestingly, cancer cell transmigration includes an additional step, which we term 'incorporation', into the endothelial cell (EC) monolayer. During this phase, cancer cells physically displace ECs, leading to the dislocation of EC VE-cadherin away from EC junctions bordering cancer cells, and spread into the monolayer. In some cases, ECs completely detach from the matrix. Furthermore, cancer cell incorporation occurs independently of the activation status and the subendothelial substrate stiffness for breast cancer and melanoma cells, a notable difference from the process by which leukocytes transmigrate. Meanwhile, pancreatic cancer cell incorporation was dependent on the activation status of the endothelium and changed on very stiff subendothelial substrates. Collectively, our results provide mechanistic insights into tumor cell extravasation and demonstrate that incorporation is one of the earliest steps.http://europepmc.org/articles/PMC4183660?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Susan M Hamilla
Kimberly M Stroka
Helim Aranda-Espinoza
spellingShingle Susan M Hamilla
Kimberly M Stroka
Helim Aranda-Espinoza
VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.
PLoS ONE
author_facet Susan M Hamilla
Kimberly M Stroka
Helim Aranda-Espinoza
author_sort Susan M Hamilla
title VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.
title_short VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.
title_full VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.
title_fullStr VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.
title_full_unstemmed VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.
title_sort ve-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Metastasis is accountable for 90% of cancer deaths. During metastasis, tumor cells break away from the primary tumor, enter the blood and the lymph vessels, and use them as highways to travel to distant sites in the body to form secondary tumors. Cancer cell migration through the endothelium and into the basement membrane represents a critical step in the metastatic cascade, yet it is not well understood. This process is well characterized for immune cells that routinely transmigrate through the endothelium to sites of infection, inflammation, or injury. Previous studies with leukocytes have demonstrated that this step depends heavily on the activation status of the endothelium and subendothelial substrate stiffness. Here, we used a previously established in vitro model of the endothelium and live cell imaging, in order to observe cancer cell transmigration and compare this process to leukocytes. Interestingly, cancer cell transmigration includes an additional step, which we term 'incorporation', into the endothelial cell (EC) monolayer. During this phase, cancer cells physically displace ECs, leading to the dislocation of EC VE-cadherin away from EC junctions bordering cancer cells, and spread into the monolayer. In some cases, ECs completely detach from the matrix. Furthermore, cancer cell incorporation occurs independently of the activation status and the subendothelial substrate stiffness for breast cancer and melanoma cells, a notable difference from the process by which leukocytes transmigrate. Meanwhile, pancreatic cancer cell incorporation was dependent on the activation status of the endothelium and changed on very stiff subendothelial substrates. Collectively, our results provide mechanistic insights into tumor cell extravasation and demonstrate that incorporation is one of the earliest steps.
url http://europepmc.org/articles/PMC4183660?pdf=render
work_keys_str_mv AT susanmhamilla vecadherinindependentcancercellincorporationintothevascularendotheliumprecedestransmigration
AT kimberlymstroka vecadherinindependentcancercellincorporationintothevascularendotheliumprecedestransmigration
AT helimarandaespinoza vecadherinindependentcancercellincorporationintothevascularendotheliumprecedestransmigration
_version_ 1716804746523705344